The Cancer Registry of Vanguard MacNeal Hospital takes part in administrative and programmatic planning, patient treatment planning, research, staging and continuity of care through data retrieval and monitoring of outcomes, through annual analysis and long-term follow-up. Since the registry was established in 1999 it has recorded more than 7,000 cases, adding more than 600 per year.
Every year, the registry enables the cancer program staff to do a thorough evaluation of the largest patient group and compare outcomes with other institutions in the state and nationwide. In 2009, prostate cancer was the fourth most commonly treated cancer at Vanguard MacNeal. Comparative analysis shows that five-year survival is consistent with other Illinois hospitals and the National Cancer Data Base, with Vanguard MacNeal having the highest survival rate for patients diagnosed with Stage 3 prostate cancer.